---
title: 'Medicine ğŸŠâ­'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Gastrointestinal / æ¶ˆåŒ–ç®¡

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Gastritis / èƒƒç‚
* **Acute gastritis / Gastropathy**
  * Concept: Inflammation of gastric mucosa (gastritis), epithelial damage (gastropathy)
  * Pathogenesis: Disruption of mucosal protection (NSAIDs, alcohol, bile reflux, stress)
  * Morphology: Intact epithelium, erosions, petechiae, hemorrhages
  * Clinical: Epigastric pain, nausea, vomiting, bleeding
* **Stree-related mucosal disease**
  * Concept: Gastropathy due to physical stress in critically ill patients
  * Pathogenesis: Mucosal injury from local ischemia (trauma, burns, intracranial disease)
  * Morphology: Erosion, perforation (often multiple)
  * Clinical: Asymptomatic, bleeding
* **Helicobacter pylori gastritis**
  * Concept: Chronic gastritis caused by Helicobacter pylori infection
  * Pathogenesis: H. pylori colonize mucosa, cause inflammation and atrophy
  * Morphology: H. pylori present, inflammatory infiltrate
  * Clinical: Asymptomatic, abdominal pain, peptic ulcer disease, gastric cancer
* **Autoimmune atrophic gastritis**
  * Concept: Chronic gastritis and atrophy caused by autoimmune
  * Pathogenesis: Antibody to parietal cells (defective acid production, hypergastrinema), antibody to intrinsic factor (vitamin B12 deficiency, pernicious anemia)
  * Morphology: Mucosal atrophy, loss of parietal cells, inflammatory infiltrate
  * Clinical: Anemia, neurological disturbances
* **Uncommon forms of gastritis**
  * Concept: Eosinophilic gastritis, lymphocytic gastritis, granulomatous gastritis
* **Peptic ulcer disease**
  * Concept: Chronic ulcer in stomach or duodenum
  * Pathogenesis: Imbalances between protective and damaging forces (H. pylori infection, NSAIDs)
  * Morphology: Punched-out defect, inflammation
  * Clinical: Epigastric pain, hemorrhage, perforation
{: .notice--info}

### Gastric Tumors / èƒƒè…«ç˜
* **Menetrier disease**
  * Concept: Giant hypertrophy of gastric rugae, protein loss from stomach
  * Pathogenesis: Excessive TGF-Î± production
  * Morphology: Gastric rugae enlargement, mucous cells hyperplasia, glandular atrophy
  * Clinical: Hypoproteinemia
* **Zollinger-Ellison syndrome**
  * Concept: Gastrin-secreting tumors cause excessive gastric acid secretion
  * Morphology: Gastric mucosal hypertrophy, peptic ulcers
  * Clinical: Severe peptic ulcers, diarrhea, possibly part of MEN1 
* **Inflammatory and hyperplastic polyps**
  * Concept: Common benign gastric polyps
  * Pathogenesis: Response to chronic gastritis (often H. pylori infection)
  * Morphology: Enlongated glands, inflammation
* **Fundic gland polyps**
  * Concept: Benign gastric polyps in fundus and body
  * Pathogenesis: PPI use, germline APC mutation (familial adenomatous polyposis)
  * Morphology: Cystically dilated fundic glands
* **Gastric adenoma**
  * Concept: Precancerous lesions that can progress to adenocarcinoma
  * Pathogenesis: Chronic gastritis with atrophy and intestinal metaplasia
  * Morphology: Polypoid lesions with low-grade or high-grade dysplasia
* **Gastric adenocarcinoma**
  * Concept: Malignant tumor from gastric epithelial cells
  * Pathogenesis: Associaged with H. pylori infection, dietary factors
    * Intestinal-type: Increased Wnt signaling (APC mutation)
    * Diffuse-type: E-cadherin loss (CDH1 mutation)
  * Morphology:
    * Intestinal-type: Glandular structures, bulky tumors
    * Diffuse-type: Discohesive signet-ring cells, linitis plastica
  * Clinical: Asymptomatic, epigastric pain, weight loss, hemorrhage
* **Lymphoma**
  * Concept: Lymphatic cancer in GI tract
  * Pathogenesis: Chronic inflammation (often H. pylori infection) induce MALT and cause gene translocation
  * Morphology: Stomach wall stickening, neoplastic lymphocytes infiltrates
  * Clinical: Epigastric pain, weight loss, hemorrhage
* **Neuroendocrine neoplasms**
  * Concept: Tumor from neuroendocrine cells in GI tract, vary from benign to malignant
  * Morphology: Uniform cells with salt and papper nucleus, well to poorly differentiated
  * Clinical: Asymptomatic, hormone production (Zollinger-Ellison syndrome, Carcinoid syndrome)
* **Gastrointestinal stromal tumor**
  * Concept: Tumor from interstitial cells of Cajal in GI tract
  * Pathogenesis: KIT mutation, PDGFRA mutation
  * Morphology: Well-circumscribed mass, spindle or epithelioid cells, CD117 positive
  * Clinical: Asymptomatic, mass effects, bleeding
{: .notice--info}

### Enterocolitis / è…¸ç‚

Cholera
Campylobacter enterocolitis
Shigellosis
Salmonella
Typhoid fever
Yersinia
Escherichia coli
Pseudomembranous colitis
Whipple disease
Viral gastroenteritis
Parasitic enterocolitis
Irritable bowel syndrome
Crohn disease
Ulcerative colitis
Indeterminate colitis
Diversion colitis
Microscopic colitis
Graft-versus-host disease
Acute appendicitis
Peritoneal infection
Sclerosing retroperitonitis

{: .notice--info}

### Intestinal Tumor / è…¸è…«ç˜

Hyperplastic polyps
Inflammatory polyps
Juvenile polyps
Peutz-Jeghers syndrome
Neoplastic polyps
Familial adenomatous polyposis
Hereditary non-polyposis colorectal cancer
Adenocarcinoma
Anal tumors
Appendix tumors
Peritoneal tumors

{: .notice--info}

### Other Intestinal Disorders / ãã®ä»–ã®è…¸ç–¾æ‚£

Hernias
Adhesions
Volvulus
Intussusception
Ischemic bowel disease
Angiodysplasia
Diverticular disease
Hemorrhoids
Cystic fibrosis
Celiac disease
Environmental enteric dysfunction
Autoimmune enteropathy
Lactase deficiency
Microvillus inclusion disease
Abetalipoproteinemia

{: .notice--info}

### Hepatitis / è‚ç‚
* **Viral hepatitis**
  * Concept: Liver damages caused by hepatotropic viruses
    * Hepatitis A: Acute hepatitis, acute liver failure
    * Hepatitis B: Acute hepatitis, acute liver failure, chronic hepatitis
    * Hepatitis C: Chronic hepatitis
    * Hepatitis D: Acute liver failure (dependent on HBV)
    * Hepatitis E: Acute hepatitis
  * Pathogenesis: 
    * Hepatitis A: Fecal-oral transmission
    * Hepatitis B: Blood transmission, sexual transmission, mother-to-child transmission
    * Hepatitis C: Blood transmission
    * Hepatitis D: Co-infection with HBV
    * Hepatitis E: Fecal-oral transmission
  * Morphology: 
    * Acute hepatitis: Portal inflammation, hepatocellular injury
    * Chronic hepatitis: Portal inflammation and fibrosis   
  * Clinical:
    * Acute hepatitis: Fever, fatigue, jaundice
    * Chronic hepatitis: Asymptomatic, biochemical and serologic evidence
* **Autoimmune hepatitis**
  * Concept: Chronic progressive hepatitis associated with autoimmune
  * Pathogenesis: Viruses or drugs trigger immune reaction, associated with specific HLA alleles
  * Morphology: Inflammation, hepatocellular injury
  * Clinical: Progress to cirrhosis 
* **Drug-induced liver injury**
  * Concept: Liver damage caused by drugs (eg. acetaminophen)
  * Pathogenesis: Injury mediated by drug metabolites through cytochrome P-450
  * Morphology: Inflammation, hepatocellular injury
  * Clinical: Abnormal live function test
* **Alcoholic liver disease**
  * Concept: Liver damage caused by long-term alcohol comsumption
  * Pathogenesis: Increased NADH (steatosis), acetaldehyde and ROS (hepatocyte injury)
  * Morphology:  Steatosis, lobular inflammation, ballooned hepatocytes, fibrosis
  * Clinical: Asymtomatic (steatosis), malaise and abnormal lab findings (hepatitis), hepatic dysfunction (cirrhosis)
* **Nonalcoholic fatty liver disease**
  * Concept: Fatty liver independent of alcohol, associated with metabolic syndrome
  * Pathogenesis: Unknown, insulin resistance related
  * Morphology: Steatosis, lobular inflammation, ballooned hepatocytes, fibrosis
  * Clinical: Asymptomatic
* **Acute liver failure**
  * Concept: Acute dysfunction of normal liver
  * Pathogenesis: Viral hepatitis, drug-induced liver injury
  * Morphology: Massive hepatic necrosis
  * Clinical: Cholestasis, hepatic encephalopathy, coagulopathy
* **Chronic liver failure / Cirrhosis**
  * Concept: Advanced fibrosis in chronic liver diseases
  * Pathogenesis: Viral hepatitis, autoimmune hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease
  * Morphology: Nodules surrounded by fibrosis
  * Clinical:
    * Impaired synthesis: Edema (albumin), coagulopathy (clotting factors)
    * Impaired metabolism: Jaundice (bilirubin), palmar erythema & spider angiomas & gynecomastia (estrogen), hepatic encepalopahty (ammonia)
    * Portal hypertension: Ascites, caput medusa, esophageal varices, splenomegaly
{: .notice--info}

### Hepatic Tumors / è‚è…«ç˜
* **Focal nodular hyperplasia**
  * Concept: Benign non-neoplastic lesion
  * Pathogenesis: Altered blood flow leads to hepatocytes hyperplastic changes
  * Morphology: Central stellate scar
  * Clinical: Asymptomatic
* **Cavernous hemangioma**
  * Concept: Most common benign liver tumor
  * Morphology: Dilated vascular channels
* **Hepatocellular adenoma**
  * Concept: Benign tumor associated with oral contreceptive and anabolic steriods
  * Pathogenesis: HNF1Î±-inactivated, inflammatory, Î²-catenin-activated
  * Morphology: Tumor without portal tracts
  * Clinical: Rupture or malignant transformation
* **Hepatoblastoma**
  * Concept: Most common malignant liver tumor of early childhood
  * Pathogenesis: Activation of Wnt signaling pathway
  * Morphology: Epithelial type, mixed type
  * Clinical: Abdominal swelling
* **Hepatocellular carcinoma**
  * Concept: Malignant liver tumor from hepatocytes, associated with chronic liver diseases (HBV, HCV, alcoholic)
  * Pathogenesis: Chronic injury, inflammation, and regeneration lead to acquisition of driver mutations 
  * Morphology: Sheets or trabeculae of tumor cells resembling normal hepatocytes
  * Clinical: Abdominal pain and fatigue (nonspecific), jaundice and ascitis (progressed)
* **Metastatic liver tumor**
  * Concept: Metastasis from colon, pancreas, lung, breast, etc.
{: .notice--info}

### Other Liver Disorders / ãã®ä»–ã®è‚è‡“ç–¾æ‚£
* **Hemochromatosis**
  * Concept: Excessive iron deposition in liver, pancreas, heart
  * Pathogenesis:
    * Hereditary: HFE mutation
    * Secondary: Red cell transfusion
  * Morphology: Hemosiderin deposition
  * Clinical: Hepatomegaly and cirrhosis, diabetes mellitus, cardiac dysfunction, skin pigmentation
* **Wilson disease**
  * Concept: Copper deposition in liver, basal ganglia, cornea
  * Pathogenesis: ATP7B mutation impair copper excretion into bile amd incorporation into ceruloplasmin
  * Morphology: Varied liver damage
  * Clinical: Liver dysfunction, extrapyramidal symptoms, Kayser-Fleischer ring
* **Î±1-Antitrypsin deficiency**
  * Concept: Protein folding disorder with low circulating Î±1-Antitrypsin
  * Pathogenesis: Uninhibited elastase (pulmonary emphysema), misfolded protein accumulation (liver disease)
  * Morphology: Cytoplasmic globular inclusions
  * Clinical: Cirrhosis, pulmonary emphysema
* **Hereditary hyperbilirubinemia**
* **Primary hepatolithiasis**
* **Hepatic vein thrombosis**
* **Sinusoidal obstruction syndrome**
* **Preeclampsia / Eclampsia**
* **Acute fatty liver of pregnancy**
{: .notice--info}

### Biliary Disorders / èƒ†é“ç–¾æ‚£
* **Extrahepatic biliary atresia**
* **Choledochal cyst**
* **Fibropolycystic disease**
* **Cholelithiasis**
  * Concept: Stones formed in biliary tract
  * Pathogenesis:
    * Cholesterol stones: Cholesterol monohydrate, caused by cholesterol supersaturation in bile
    * Pigment stones: Bilirubin calcium, caused by hemolytic anemia or bacterial infections
  * Morphology:
    * Cholesterol stones: Pale yellow, radiating palisade
    * Pigment stones: Brown to black, laminated
  * Clinical: Asymptomatic, colicky pain after meals
* **Acute cholecystitis**
  * Concept: Acute inflammation of gallbladder
  * Pathogenesis: Gallstones obstruction, superimposed bacterial infections
  * Morphology: Thickened walls, cloudy bile
  * Clinical: Fever, RUQ pain, jaundice
* **Chronic cholecystitis**
  * Concept: Chronic inflammation of gallbladder
  * Pathogenesis: Gallstones (obstruction not required)
  * Morphology: Inflammation, Rokitansky-Aschoff sinuses
  * Clinical: Recurrent colicky pain
* **Primary biliary cholangitis**
* **Primary sclerosing cholangitis**
* **Gallbladder carcinoma**
  * Concept: Malignant tumor from gallbladder
  * Pathogenesis: Gallstones
  * Morphology: Adenocarcinoma, glandular structures
  * Clinical: Pain, jaundice
* **Malignant biliary tumors**
  * Concept: Malignant tumor from intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or extrahepatic bile duct (biliary adenocarcinoma)
  * Pathogenesis: Chronic inflammation of bile ducts (hepatolithiasis, primary sclerosing cholangitis, liver fluke infection)
  * Morphology: Adenocarcinoma, glandular structures
  * Clinical: Asymptomatic (intrahepatic), obstructive jaundice (extrahepatic)
{: .notice--info}

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Esophageal Disorders / é£Ÿé“ç–¾æ‚£

## Gastric and Duodenal Disorders / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜

## Intestine and Anal Disorders / è…¸ãƒ»è‚›é–€ç–¾æ‚£

## Diaphragm and Abdominal Wall Disorders / æ¨ªéš”è†œãƒ»è…¹å£ç–¾æ‚£

## Liver Disorders / è‚ç–¾æ‚£

## Biliary System Disorders / èƒ†é“ç³»ç–¾æ‚£

## Pancreas Disorders / è†µç–¾æ‚£

# Cardiovascular / å¾ªç’°å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£

## Valvular Heart Disease / å¿ƒå¼è†œç—‡

## Endocardium, Myocardium, and Pericardium Disorders / å¿ƒå†…è†œãƒ»å¿ƒç­‹ãƒ»å¿ƒè†œç–¾æ‚£

## Arrhythmia / ä¸æ•´è„ˆ

## Arterial Disorders / å‹•è„ˆç–¾æ‚£

## Venous Disorders / é™è„ˆç–¾æ‚£

## Blood Pressure Abnormalities / è¡€åœ§ç•°å¸¸

# Respiratory / å‘¼å¸å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Infectious Diseases / æ„ŸæŸ“æ€§ç–¾æ‚£
* **Bacterial pneumonia**
  * Concept: Lung bacterial infection. Can be community-acquired (often after viral infection), health care-associated, hospital-acquired, aspiration
    * Streptococcus pneumoniae: Commonly cause community-acquired pneumonia
    * Haemophilus influenzae: Commonly cause community-acquired pneumonia and COPD acute exaceberation
    * Moraxella catarrhalis: Commonly cause COPD acute exaceberation
    * Staphylococcus aureus: High incidence of complication
    * Klebsiella pneumoniae: Commonly infect debilitated patients
    * Pseudomonas aeruginosa: Commonly cause hospital-acquired pneumonia
    * Legionella pneumophila: Transmitted in artificial aquatic environments, may be severe
    * Mycoplasma pneumoniae: Commonly infect children and young adults
  * Morphology:
    * Lobar pneumonia: Entire lobe consolidation. Congestion, red hepatization, gray hepatization, resolution
    * Bronchopneumonia: Patchy consolidation
  * Clinical: Cough with sputum, fever
* **Viral pneumonia**
  * Concept: Lung viral infection
    * Influenza virus: Influenza A can cause pneumonia or subsequent bacterial pneumonia
    * Human coronavirus: SARS-CoV-2 can cause severe or fatal pneumonia
  * Morphology: Interstitial inflammation involving alveolar walls
  * Clinical: Fever, cough (may be absent)
* **Lung abscess**
  * Concept: Suppurative disease of lung
  * Pathogenesis: Aspiration of pathogens, antecedent lung infection
  * Morphology: Abscesses, cavitation
  * Clinical: Cough, fever, foul-smelling sputum
* **Chronic pneumonia**
  * Concept: Granulomatous infection of lung
    * Mycobacterium
    * Histoplasma
    * Blastomyces
    * Coccidioides
  * Morphology: Granulomas, yeasts 
  * Clinical: Resolve spontaneuously or progress
* **Pneumonia in immunocompromised host**
  * Concept: Opportunistic infections in immonocompromised host
    * Cytomegalovirus
    * Pneumocystis jiroveci
    * Aspergillus
    * Candida
{: .notice--info}

### Obstructive Lung Diseases / é–‰å¡æ€§è‚ºç–¾æ‚£
* **Overview**
  * Increase in resistance to airflow
  * Chronic obstructive pulmonary disease: Persistent respiratory symptoms mostly caused by smoking, include emphysema and chronic bronchitis
* **Emphysema**
  * Concept: Enlargement of airspaces and destruction of walls in bronchioles and alveoli
    * Centriacinar: Involve respiratory bronchioles, associated with smoking
    * Panacinar: Involve alveolar ducts and alveoli, associated with Î±1-antitrypsin deficiency
    * Parasetpal: Involve alveoli near septa and pleura, associated with pneumothorax
    * Irregular
  * Pathogenesis: Toxic injury, protease-antiprotease inbalance
  * Morphology: Abnormally large alveoli
  * Clinical: Dyspnea
* **Chronic bronchitis**
  * Concept: Persistent cough with sputum production
  * Pathogenesis: Mucus hypersecretion, CFTR dysfunction
  * Morphology: Reid index (mucous gland thickness / whole layer thickness) increases
  * Clinical: Persistent cough and sputum
* **Asthma**
  * Concept: Chronic airway inflammation, variable airway obstruction
    * Atopic: Triggered by allergens, IgE-mediated hypersensitivity
    * None-atopic: Triggered by virus, pollutants, cold exposure
    * Drug-induced: Triggered by drugs (eg. aspirin)
    * Occupational: Triggered by fumes or chemicals
  * Pathogenesis: TH2 responses, genetic susceptibility, environmental factors
  * Morphology: Increased eosinophils, Charcot-Leyden crystals, Curschmann spirals
  * Clinical: Acute dyspnea and cough, chronic mild cough
* **Bronchiectasis**
  * Concept: Permanent dilation of bronchi and bronchioles
  * Pathogenesis: Persistent infection (eg. tuberculosis), primary ciliary dyskinesia
  * Morphology: Dilated airways
  * Clinical: Severe cough and sputum (sometimes bloody)
{: .notice--info}

### Interstitial Lung Disease / é–“è³ªæ€§è‚ºç–¾æ‚£
* **Overview**
  * Inflammation of interstitium, restrictive lung disease
* **Idiopathic pulmonary fibrosis (Usual interstitial pneumonia)**
  * Concept: Progressive interstitial fibrosis and respiratory failure
  * Pathogenesis: Unknown
  * Morphology: Inhomogeneous in time and space, honeycomb fibrosis
  * Clinical: Gradually increasing dypsnea and dry cough
* **Non-specific interstitial pneumonia**
  * Concept: Often associated with connective tissue disease
  * Morphology: Homogeneous in time and space, cellular or fibrosing pattern
* **Cryptogenic organizing pneomia**
  * Concept: Often associated with infection or injury
  * Morphology: Polyps in alveoli and bronchioles
* **Pulmonary involvement of autoimmune disease**
  * Concept: Involvement of rheumatoid arthritis, systemic sclerosis, or lupus erythematosus
* **Coal worker's pneumoconiosis**
  * Concept: Caused by inhalation of coal particles
  * Morphology: Anthracosis, coal macules and nodules
  * Clinical: Little decrement in lung function
* **Silicosis**
  * Concept: Caused by inhalation of silica
  * Pathogenesis: Silica phagocytosed by macrophages, activate inflammation
  * Morphology: Collagenous nodules
  * Clinical: Varied progression, increase risk of tuberculosis and lung cancer
* **Asbestosis**
  * Concept: Caused by inhalation of asbestos
  * Pathogenesis: Asbestos phagocytosed by macrophages, activate inflammation
  * Morphology: Fibrosis, asbestos bodies
  * Clinical: Late progression, increase risk of lung cancer and mesothelioma
* **Drug-induced lung diseases**
  * Concept: Caused by bleomycin, amiodarone, etc.
* **Radiation-incuded lung diseases**
  * Concept: Caused by radiotherapy
* **Sarcoidosis**
  * Concept: Systemic granulomatous disease
  * Pathogenesis: Unknown
  * Morphology: Non-necrotizing granulomas
  * Clinical: diverse involvement of lung, lymph node, skin, or eye
* **Hypersensitivity pneumonitis**
  * Concept: Caused by inhalation of antigen
  * Pathogenesis: Immunologic
  * Morphology: Non-necrotizing granulomas, inflammatory infiltration
  * Clinical: Fever, cough, dyspnea
* **Pulmonary eosinophilia**
  * Concept: Infiltration of eosinophils
  * Clinical: Fever, cough, dyspnea
* **Desquamative interstitial pneumonia**
  * Concept: Smoking-related
  * Morphology: Accumulation of dusty macrophages in alveoli
* **Respiratory bronchiolitis-associated interstitial lung disease**
  * Concept: Smoking-related
  * Morphology: Accumulation of dusty macrophages in bronchioles
* **Pulmonary Langerhans cell histiocytosis**
  * Concept: Smoking-related
  * Morphology: Collection of grooved Langerhans cells
* **Pulmonary alveolar proteinosis**
  * Concept: Accumulation of surfactant in alveoli
  * Pathogenesis: Defect in macraphages GM-CSF signaling, mostly autoimmune
  * Morphology: Accumulation of eosinophilic precipitate in alveoli
  * Clinical: Cough, sputum, dyspnea
* **Surfactant dysfunction disorders**
  * Concept: Mutation in surfactant-related gene
  * Morphology: Eosinophilic material in alveoli
{: .notice--info}

### Pulmonary Vascular Disorders / è‚ºå¾ªç’°éšœå®³
* **Pulmonary embolism and infarction**
  * Concept: Emboli (usually from deep vein thromboses) occlude pulmonary artery
  * Pathogenesis: In patients with increased tendency to clot
  * Morphology: Large emboli in pulmonary artery, hemorrhagic when infarct
  * Clinical: Dyspnea, chest pain, shock
* **Pulmonary hypertension**
  * Concept: Mean pulmonary artery pressure > 25 mmHg
  * Pathogenesis: Idiopathic (with genetic basis), left heart disease, lung disease or hypoxia, chronic pulmonary emboli
  * Morphology: Hypertropy of pulmonary circulation arteries and right ventricle
  * Clinical: Dyspnea, chest pain, cyanosis, right heart failure
* **Goodpasture syndrome**
  * Concept: Kidney and lung injuries caused by anti-glomerular basement membrane antibody
  * Pathogenesis: Antibodieas against collagen IV Î±3 chain destruct basement membrane in renal glomeruli and pulmonary alveoli
  * Morphology: Hemorrhage, hemosiderin-laden macrophages
  * Clinical: Hemoptysis, glomerulonephritis
* **Pulmonary edema**
  * Concept: Excessive fluid in alveoli, lead to hypoxemia
    * Hemodynamic disturbances: Increased hydrostatic pressure (left-sided heart failure)
    * Microvascular injury: Inflammatory exudate (acute respiratory distress syndrome)
{: .notice--info}

### Lung Tumors / è‚ºè…«ç˜
* **Lung carcinoma**
  * Concept: Malignant tumor from respiratory epithelium
  * Pathogenesis: Exposure to carcinogens leads to accumulation of driver mutations (tobacco smoking, industrial hazards, air pollution)
  * Morphology:
    * Adenocarcinoma: Gland formation, mucin production
    * Squamous cell carcinoma: Keratinization, intercellular bridges
    * Small cell carcinoma: Clusters of small cells
    * Large cell carcinoma: Undifferentiated large cells
  * Clinical:
    * Symptoms: Asymptomatic, cough, chest pain, dyspnea
    * Local effects: Hoarseness, diaphragm paralysis, pleural effusion, SVC syndrome, Pancoast syndrome
    * Paraneoplastic syndromes: SIADH, Cushing syndrome, hypercalcemia, Lambert-Eaton syndrome
* **Carcinoid tumors**
  * Concept: Low-grade malignant tumor from neuroendocrine cells
  * Morphology: Nests of relatively regular cells
  * Clinical: Cough, carcinoid syndrome (intermittent diarrhea and flushing)
* **Miscellaneous tumors**
  * Concept: Benign and malignant mesenchymal tumors
    * Hamartoma: Most common lung benign tumor
    * Lymphangioleiomyomatosis: Mostly in women of childbearing age
    * Inflammatory myofibroblastic tumor: Rare tumor in children
* **Metastatic lung tumors**
  * Concept: Lung is the most common site of metastasis
  * Morphology: Multiple discrete nodules
{: .notice--info}

### Other Lung Disorders / ãã®ä»–ã®è‚ºè‡“ç–¾æ‚£
* **Atelectasis**
  * Concept: Incomplete expansion of lungs. From resorption (obstruction), compression, contraction (fibrosis)
* **Pulmonary hypoplasia**
  * Concept: Defect in lung development
* **Foregut cysts**
  * Concept: Abnormal cysts from foregut
* **Pulmonary sequestration**
  * Concept: Discrete area of lung tissue that (1) is not connected to airways (2) has abnormal blood supply from aorta
* **Acute respiratory distress syndrome**
  * Concept: Abrupt onset of pulmonary edema and hypoxemia, due to increased capillary permeability
  * Pathogenesis: Endothelial activation, neutrophil extravasation, fluid accumulation, hyaline membrane formation. Caused by pneumonia, sepsis, oxegen therapy
  * Morphology: Diffuse alveolar damage, hyaline membranes
  * Clinical: Dyspnea, hypoxemia, bilateral infiltration
* **Lung transplantation**
  * Concept: Transplanted lung is subject to infection and rejection
  * Morphology: Inflammatory infiltrates (acute rejection), bronchiolitis obliterans (chronic rejection)
{: .notice--info}

### Pleural Disorders / èƒ¸è†œç–¾æ‚£
* **Pleural effusion**
  * Concept: Accumulation of fliuds in pleural cavities
    * Inflammatory: From infections, cancers, autoimmune diseases
    * Noninflammatory: From heart failure, renal failure, cirrhosis
* **Pneumothorax**
  * Concept: Gas in pleural cavities. Can be spontaneous, traumatic, therapeutic
* **Solitary fibrous tumor**
  * Concept: Tumor in pleura
  * Morphology: Spindle cells among fibers
* **Malignant mesothelioma**
  * Concept: Malignant tumor in pleural cavities
  * Pathogenesis: Related to asbestos
  * Morphology: Epithelioid, sarcomatoid, biphasic
  * Clinical: Chest pain, dyspnea, pleural effusions
{: .notice--info}

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infectious Diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Obstructive Lung Diseases / é–‰å¡æ€§è‚ºç–¾æ‚£

## Interstitial Lung Diseases / é–“è³ªæ€§è‚ºç–¾æ‚£

## Immune and Allergic Diseases / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§ç–¾æ‚£

## Pulmonary Vascular Disorders / è‚ºå¾ªç’°éšœå®³

## Lung Tumors / è‚ºè…«ç˜

## Lungs and Bronchi Abnormalities / è‚ºãƒ»æ°—ç®¡æ”¯ã®å½¢æ…‹ç•°å¸¸

## Functional Respiratory Disorders / æ©Ÿèƒ½çš„å‘¼å¸éšœå®³

## Mediastinal Disorders / ç¸¦éš”ç–¾æ‚£

## Pleural and Chest Wall Disorders / èƒ¸è†œãƒ»èƒ¸å£ç–¾æ‚£

# Renal and Urological / è…ãƒ»æ³Œå°¿å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Glomerular Disorders / ç³¸çƒä½“ç–¾æ‚£

## Tubulointerstitial Disorders / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

## Renal Disorders with Systemic Diseases / å…¨èº«ç–¾æ‚£ã«ä¼´ã†è…éšœå®³

## Renal Vascular Disorders / è…å¾ªç’°éšœå®³

## Stones and Tumors / çµçŸ³ã¨è…«ç˜

## Infections / æ„ŸæŸ“ç—‡

## Functional Disorders / æ©Ÿèƒ½éšœå®³

## Water and Electrolyte Metabolism Disorders / æ°´ãƒ»é›»è§£è³ªä»£è¬ç•°å¸¸

# Metabolism and Endocrine / ä»£è¬ãƒ»å†…åˆ†æ³Œ

## Biochemistry / ç”ŸåŒ–å­¦

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Hypothalamus and Pituitary Disorders / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ç–¾æ‚£

## Thyroid Disorders / ç”²çŠ¶è…ºç–¾æ‚£

## Parathyroid Disorders / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

## Adrenal Gland disorders / å‰¯è…ç–¾æ‚£

## Other Endocrine Disorders / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£

## Carbohydrate Metabolism Disorders / ç³–è³ªä»£è¬ç•°å¸¸

## Lipid Metabolism Disorders / è„‚è³ªä»£è¬ç•°å¸¸

## Amino Acid Metabolism Disorders / ã‚¢ãƒŸãƒé…¸ä»£è¬ç•°å¸¸

## Other Metabolic Disorders / ãã®ä»–ã®ä»£è¬ç•°å¸¸

## Nutritional Abnormalities / æ „é¤Šã®ç•°å¸¸

# Hematology / è¡€æ¶²

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Red Blood Cell Abnormalities / èµ¤è¡€çƒç³»ã®ç•°å¸¸

## White Blood Cell Abnormalities / ç™½è¡€çƒç³»ã®ç•°å¸¸

## Hemostasis and Coagulation Abnormalities / æ­¢è¡€ãƒ»å‡å›ºç³»ã®ç•°å¸¸

# Immune and Connective Tissue Diseases / å…ç–«ãƒ»è† åŸç—…

## Immunology / å…ç–«å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Immunodeficiency / å…ç–«ä¸å…¨

## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

## Connective Tissue Disease / è† åŸç—…

# Infectious Diseases / æ„ŸæŸ“ç—‡

## Microbiology / å¾®ç”Ÿç‰©å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Bacterial Infections / ç´°èŒæ„ŸæŸ“ç—‡

## Viral Infections / ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## Fungal Infections / çœŸèŒæ„ŸæŸ“ç—‡

## Parasitic Infections / å¯„ç”Ÿè™«æ„ŸæŸ“ç—‡

# Neurology / ç¥çµŒ

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Cerebrovascular disorders / è„³è¡€ç®¡ç–¾æ‚£

## Dementia disorders / èªçŸ¥ç—‡æ€§ç–¾æ‚£

## Demyelinating disorders / è„±é«„æ€§ç–¾æ‚£

## Degenerative disorders / å¤‰æ€§ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Muscle disorders / ç­‹ç–¾æ‚£

## Peripheral nerve disorders / æœ«æ¢¢ç¥çµŒç–¾æ‚£

## Functional seizure disorders / æ©Ÿèƒ½æ€§ç™ºä½œæ€§ç–¾æ‚£

## Neurocutaneous syndromes / æ¯æ–‘ç—‡

## Brain tumors / è„³è…«ç˜

## Head injuries / é ­éƒ¨å¤–å‚·

## Malformations / å¥‡å½¢

# Pediatrics / å°å…ç§‘

## Neonates / æ–°ç”Ÿå…

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Gastrointestinal disorders / æ¶ˆåŒ–å™¨ç–¾æ‚£

## Cardiovascular disorders / å¾ªç’°å™¨ç–¾æ‚£

## Respiratory disorders / å‘¼å¸å™¨ç–¾æ‚£

## Renal and urological disorders / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

## Metabolic and endocrine disorders / ä»£è¬ãƒ»å†…åˆ†æ³Œç–¾æ‚£

## Hematological and hematopoietic disorders / è¡€æ¶²ãƒ»é€ è¡€å™¨ç–¾æ‚£

## Immune and allergic disorders / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“ç—‡

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Tumors / è…«ç˜

# Gynecology / å©¦äººç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Menstrual abnormalities / æœˆçµŒã®ç•°å¸¸

## Abnormalities in sexual differentiation and genital morphology / æ€§åˆ†åŒ–ã¨æ€§å™¨å½¢æ…‹ã®ç•°å¸¸

## Genital inflammation and sexually transmitted infections / æ€§å™¨ã®ç‚ç—‡ãƒ»æ€§æ„ŸæŸ“ç—‡

## Infertility / ä¸å¦Š

## Age-related changes / åŠ é½¢ã«ä¼´ã†å¤‰åŒ–

## Benign tumors, pre-cancerous lesions, and neoplasms / é¡è…«ç˜ç—…å¤‰ãƒ»å‰ç™Œç—…å¤‰ãƒ»è…«ç˜

## Breast disorders / ä¹³è…ºç–¾æ‚£

# Obstetrics / ç”£ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Abnormalities in pregnancy / å¦Šå¨ ã®ç•°å¸¸

## Complicated pregnancies and mother-child infections / åˆä½µç—‡å¦Šå¨ ãƒ»æ¯å­æ„ŸæŸ“

## Abnormalities in childbirth / åˆ†å¨©ã®ç•°å¸¸

## Postpartum period / ç”£è¤¥

# Urology / æ³Œå°¿å™¨ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infections / æ„ŸæŸ“ç—‡

## Tumors / è…«ç˜

## Male Genital Disorders / ç”·æ€§å™¨ç–¾æ‚£

## Sexual Dysfunction / æ€§æ©Ÿèƒ½éšœå®³

# Orthopedics / æ•´å½¢å¤–ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Fractures / éª¨æŠ˜

## Dislocations / è„±è‡¼

## Spinal cord and spinal disorders / è„Šæ¤ãƒ»è„Šé«„ç–¾æ‚£

## Upper limb disorders / ä¸Šè‚¢ã®ç–¾æ‚£

## Lower limb disorders / ä¸‹è‚¢ã®ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Peripheral nerve injuries / æœ«æ¢¢ç¥çµŒæå‚·

## Metabolic bone disorders / ä»£è¬æ€§éª¨ç–¾æ‚£

## Tumors / è…«ç˜

# Ophthalmology / çœ¼ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Refractive and accommodative abnormalities / å±ˆæŠ˜ãƒ»èª¿ç¯€ç•°å¸¸

## Eyelid and lacrimal system disorders / çœ¼ç¼ãƒ»æ¶™å™¨ç–¾æ‚£

## Conjunctival, corneal, and scleral disorders / çµè†œãƒ»è§’è†œãƒ»å¼·è†œç–¾æ‚£

## Uveal disorders / ã¶ã©ã†è†œç–¾æ‚£

## Retinal and vitreous disorders / ç¶²è†œãƒ»ç¡å­ä½“ç–¾æ‚£

## Optic nerve disorders / è¦–ç¥çµŒç–¾æ‚£

## Lens disorders / æ°´æ™¶ä½“ç–¾æ‚£

## Glaucoma / ç·‘å†…éšœ

## Ocular trauma / çœ¼å¤–å‚·

# Otorhinolaryngology / è€³é¼»å’½å–‰ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Inner ear disorders / å†…è€³ç–¾æ‚£

## Middle ear disorders / ä¸­è€³ç–¾æ‚£

## Outer ear disorders / å¤–è€³ç–¾æ‚£

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Nasal and sinus disorders / é¼»è…”ãƒ»å‰¯é¼»è…”ç–¾æ‚£

## Oral, tonsil, and salivary gland disorders / å£è…”ãƒ»æ‰æ¡ƒãƒ»å”¾æ¶²è…ºç–¾æ‚£

## Pharyngeal and laryngeal disorders / å’½é ­ãƒ»å–‰é ­ç–¾æ‚£

# Dermatology / çš®è†šç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Eczema and dermatitis group / æ¹¿ç–¹ãƒ»çš®è†šç‚ç¾¤

## Urticaria and itching group / è•éº»ç–¹ãƒ»æ»ç—’ç¾¤

## Erythema / ç´…æ–‘ç—‡

## Bullous diseases / æ°´ç–±ç—‡

## Pustular diseases / è†¿ç–±ç—‡

## Pigmentation disorders / è‰²ç´ ç•°å¸¸ç—‡

## Nevus / æ¯æ–‘ç—‡

## Keratosis disorders / è§’åŒ–ç•°å¸¸

## Benign tumors / è‰¯æ€§è…«ç˜

## Malignant tumors / æ‚ªæ€§è…«ç˜

## Metabolic disorders / ä»£è¬ç•°å¸¸

# Psychiatry / ç²¾ç¥ç§‘

## Behavior Science / è¡Œå‹•ç§‘å­¦

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Neurotic disorders / ç¥çµŒç—‡æ€§éšœå®³

## Mood disorders and schizophrenia / æ°—åˆ†éšœå®³ãƒ»çµ±åˆå¤±èª¿ç—‡

## Substance-related disorders / ç‰©è³ªé–¢é€£éšœå®³

## Physiological disorders / ç”Ÿç†çš„éšœå®³

## Neurodevelopmental disorders / ç¥çµŒç™ºé”ç—‡ç¾¤

